The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents (Q33726292)

28 July 2017

1 reference

title

The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents (English)

1 reference

28 July 2017

V T Andriole

1

1 reference

PubMed ID

10473222

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

Journal of Antimicrobial Chemotherapy

28 July 2017

1 reference

28 July 2017

44

1 reference

28 July 2017

2

1 reference

28 July 2017

151-162

1 reference

Impact of the changing epidemiology of fungal infections in the 1990s

28 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Opportunistic and pathogenic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

How do the polyene macrolide antibiotics affect the cellular membrane properties?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Amphotericin B: an introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.151

21 January 2018

Identifiers

DOI

10.1093/JAC/44.2.151

1 reference

28 July 2017

1 reference

PubMed ID

10473222